Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 3
2011 1
2012 1
2013 3
2014 2
2015 4
2016 3
2017 2
2018 3
2019 1
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Antitumoral alkylphospholipids alter cell lipid metabolism.
Marco C, Ríos-Marco P, Jiménez-López JM, Segovia JL, Carrasco MP. Marco C, et al. Among authors: rios marco p. Anticancer Agents Med Chem. 2014 May;14(4):545-58. doi: 10.2174/1871520614666140309224707. Anticancer Agents Med Chem. 2014. PMID: 24628237 Review.
1,2-Diphenoxiethane salts as potent antiplasmodial agents.
Schiafino-Ortega S, Baglioni E, Pérez-Moreno G, Marco PR, Marco C, González-Pacanowska D, Ruiz-Pérez LM, Carrasco-Jiménez MP, López-Cara LC. Schiafino-Ortega S, et al. Among authors: marco pr. Bioorg Med Chem Lett. 2018 Aug 1;28(14):2485-2489. doi: 10.1016/j.bmcl.2018.05.060. Epub 2018 May 31. Bioorg Med Chem Lett. 2018. PMID: 29880399
Alkylphospholipids: An update on molecular mechanisms and clinical relevance.
Ríos-Marco P, Marco C, Gálvez X, Jiménez-López JM, Carrasco MP. Ríos-Marco P, et al. Biochim Biophys Acta Biomembr. 2017 Sep;1859(9 Pt B):1657-1667. doi: 10.1016/j.bbamem.2017.02.016. Epub 2017 Feb 24. Biochim Biophys Acta Biomembr. 2017. PMID: 28238819 Free article. Review.
New non-symmetrical choline kinase inhibitors.
Schiaffino-Ortega S, López-Cara LC, Ríos-Marco P, Carrasco-Jimenez MP, Gallo MA, Espinosa A, Marco C, Entrena A. Schiaffino-Ortega S, et al. Among authors: rios marco p. Bioorg Med Chem. 2013 Nov 15;21(22):7146-54. doi: 10.1016/j.bmc.2013.09.003. Epub 2013 Sep 11. Bioorg Med Chem. 2013. PMID: 24080101
Lead optimization-hit expansion of new asymmetrical pyridinium/quinolinium compounds as choline kinase α1 inhibitors.
Rubbini G, Buades-Martín AB, Kimatrai-Salvador M, Entrena A, Gallo-Mezo MÁ, Ríos-Marco P, Marco C, Mattiuzzo E, Bortolozzi R, Mariotto E, Greco FA, Macchiarulo A, Carrasco-Jiménez MP, Viola G, López-Cara LC. Rubbini G, et al. Among authors: rios marco p. Future Med Chem. 2018 Aug 1;10(15):1769-1786. doi: 10.4155/fmc-2018-0059. Epub 2018 Jul 25. Future Med Chem. 2018. PMID: 30043647
Anticancer and Structure Activity Relationship of Non-Symmetrical Choline Kinase Inhibitors.
Schiaffino-Ortega S, Mariotto E, Luque-Navarro PM, Kimatrai-Salvador M, Rios-Marco P, Hurtado-Guerrero R, Marco C, Carrasco-Jimenez MP, Viola G, López-Cara LC. Schiaffino-Ortega S, et al. Among authors: rios marco p. Pharmaceutics. 2021 Aug 29;13(9):1360. doi: 10.3390/pharmaceutics13091360. Pharmaceutics. 2021. PMID: 34575436 Free PMC article.
Anticancer Activity of the Choline Kinase Inhibitor PL48 Is Due to Selective Disruption of Choline Metabolism and Transport Systems in Cancer Cell Lines.
García-Molina P, Sola-Leyva A, Luque-Navarro PM, Laso A, Ríos-Marco P, Ríos A, Lanari D, Torretta A, Parisini E, López-Cara LC, Marco C, Carrasco-Jiménez MP. García-Molina P, et al. Among authors: rios marco p. Pharmaceutics. 2022 Feb 16;14(2):426. doi: 10.3390/pharmaceutics14020426. Pharmaceutics. 2022. PMID: 35214160 Free PMC article.
24 results